Elizabeth K. Bieber

May 23, 2024 | corpgov.law.harvard.edu | Elizabeth K. Bieber |Pamela L. Marcogliese

AI, Artificial intelligence, Climate Disclosure, Cybersecurity, GenAI, Generative AI, SECMore from: Elizabeth Bieber, Pamela Marcogliese, FreshfieldsElizabeth Bieber is a Partner and Pamela Marcogliese is Head of US Transactions at Freshfields Bruckhaus Deringer LLP. This post is based on a Freshfields memorandum by Ms. Bieber, Ms. Marcogliese, and the Freshfields Corporate Advisory group.

Feb 12, 2024 | lexology.com | Harriet Hanks |Kristen Riemenschneider |James Smith |Jake Reynolds |Elizabeth K. Bieber |Christopher Stothers | +4 more

Antimicrobial resistance (AMR) is a growing global threat: the WHO recognises it as one of the top public health and development threats, and bacterial AMR was associated with almost 5 million global deaths in a single year in one landmark study.1 AMR’s contributing factors include a lack of new antimicrobial products, limited access to antibiotics in low- and middle-income countries, and discharge of antimicrobial waste into the environment.

Oct 23, 2023 | lexology.com | Sarah K. Solum |Pamela L. Marcogliese |Elizabeth K. Bieber |Taryn Zucker |Kimberly Wang

On Wednesday, the United States Court of Appeals for the Fifth Circuit upheld Nasdaq’s board diversity rule, which encourages greater board diversity from companies listed on the exchange, in Alliance for Fair Board Recruitment v. SEC, 5th Cir., No. 21-60626.